umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Local delivery of the soluble form of the tumor suppressor and stem cell regulator LRIG1 potently inhibits in vivo growth of glioblastomas with either wildtype or mutant EGFR expression
Show others and affiliations
2013 (English)In: European Journal of Cancer, ISSN 0959-8049, E-ISSN 1879-0852, Vol. 49, no Supplement 2, S777-S777, Meeting Abstract: 3307 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Elsevier, 2013. Vol. 49, no Supplement 2, S777-S777, Meeting Abstract: 3307 p.
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-83924ISI: 000326843605061OAI: oai:DiVA.org:umu-83924DiVA: diva2:677903
Conference
17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, SEP 27-OCT 01, 2013, Amsterdam, NETHERLANDS
Available from: 2013-12-10 Created: 2013-12-10 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Hedman, Håkan
By organisation
Oncology
In the same journal
European Journal of Cancer
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 80 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf